Literature DB >> 10732811

Characterization of the rat spinocerebellar ataxia type 3 gene.

I Schmitt1, T Brattig, M Gossen, O Riess.   

Abstract

Machado-Joseph disease (MJD) belongs to a group of clinically and genetically heterogeneous neurodegenerative disorders characterized by progressive cerebellar ataxia. The disease-causing mutation has recently been identified as an unstable and expanded (CAG)n trinucleotide repeat in a novel gene of unknown function. In Caucasians, repeat expansions in the MJD1 gene have also been found in patients with the clinically distinct autosomal dominant spinocerebellar ataxia type 3 (SCA3). In order to gain insight into the biology of the MJD1/SCA3 gene we cloned the rat homologue and studied its expression. The rat and human ataxin-3 genes are highly homologous with an overall sequence identity of approximately 88%. However, the C-terminal end of the putative protein differs strongly from the published human sequence. The (CAG)n block in the rat cDNA consists of just three interrupted units suggesting that a long polyglutamine stretch is not essential for the normal function of the ataxin-3 protein in rodents. The expression pattern of the SCA3 gene in various rat and human tissues was investigated by Northern blot analyses. The mature transcript is approximately 6 kb in length. In rat testis, a smaller transcript of 1.3 kb was identified. Transcription of rsca3 was detected in most rat tissues including brain. Analyzing the expression level of the SCA3 gene in several human brain sections revealed no significant higher mRNA level in regions predominantly affected in MJD. Thus additional molecules and/or regulatory events are necessary to explain the exclusive degeneration of certain brain areas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10732811     DOI: 10.1007/s100480050015

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  6 in total

Review 1.  Toward understanding Machado-Joseph disease.

Authors:  Maria do Carmo Costa; Henry L Paulson
Journal:  Prog Neurobiol       Date:  2011-11-23       Impact factor: 11.685

2.  Lithium chloride therapy fails to improve motor function in a transgenic mouse model of Machado-Joseph disease.

Authors:  Sara Duarte-Silva; Andreia Neves-Carvalho; Carina Soares-Cunha; Andreia Teixeira-Castro; Pedro Oliveira; Anabela Silva-Fernandes; Patrícia Maciel
Journal:  Cerebellum       Date:  2014-12       Impact factor: 3.847

3.  Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease.

Authors:  Guan-Yu Lin; Chung-Yung Ma; Li-Chung Kuo; Benjamin Y Hsieh; Hanbing Wang; Chin-San Liu; Mingli Hsieh
Journal:  Metab Brain Dis       Date:  2022-04-30       Impact factor: 3.655

4.  Isolation and characterization of the rat huntingtin promoter.

Authors:  C Holzmann; W Mäueler; D Petersohn; T Schmidt; G Thiel; J T Epplen; O Riess
Journal:  Biochem J       Date:  1998-11-15       Impact factor: 3.857

5.  Genomic structure, promoter activity, and developmental expression of the mouse homologue of the Machado-Joseph disease (MJD) gene.

Authors:  Maria do Carmo Costa; Joana Gomes-da-Silva; Carlos J Miranda; Jorge Sequeiros; Manuela M Santos; Patrícia Maciel
Journal:  Genomics       Date:  2004-08       Impact factor: 5.736

Review 6.  Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.

Authors:  Melvin M Evers; Lodewijk J A Toonen; Willeke M C van Roon-Mom
Journal:  Mol Neurobiol       Date:  2013-11-29       Impact factor: 5.590

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.